M2 protocol

M2 protocol

A chemotherapeutic protocol for treating myeloma, which includes the alkylating agents vincristine, BCNU (carmustine), cyclophosphamide, melphalan and prednisone (VBCMP).

M2 protocol

Oncology A protocol for treating myeloma Agents vincristine, BCNU–carmustine, cyclophosphamide, melphalan, prednisone